Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 193 to 194 of 194 entries
Sorted by: Best Match Show Resources per page
The dimensionality of adverse childhood experiences: A scoping review of ACE dimensions measurement.

Child abuse & neglect

Krinner LM, Warren-Findlow J, Bowling J, Issel LM, Reeve CL.
PMID: 34419902
Child Abuse Negl. 2021 Nov;121:105270. doi: 10.1016/j.chiabu.2021.105270. Epub 2021 Aug 19.

OBJECTIVE: Despite extensive research, the concept of adverse childhood experiences (ACEs) is not fully developed and there is low agreement on how the concept should be defined and measured. The purpose of this study was to 1) identify different...

Cite
Krinner LM, Warren-Findlow J, Bowling J, et al. The dimensionality of adverse childhood experiences: A scoping review of ACE dimensions measurement. Child Abuse Negl. 2021;121:105270doi: 10.1016/j.chiabu.2021.105270.
Krinner, L. M., Warren-Findlow, J., Bowling, J., Issel, L. M., & Reeve, C. L. (2021). The dimensionality of adverse childhood experiences: A scoping review of ACE dimensions measurement. Child abuse & neglect, 121105270. https://doi.org/10.1016/j.chiabu.2021.105270
Krinner, Lisa M, et al. "The dimensionality of adverse childhood experiences: A scoping review of ACE dimensions measurement." Child abuse & neglect vol. 121 (2021): 105270. doi: https://doi.org/10.1016/j.chiabu.2021.105270
Krinner LM, Warren-Findlow J, Bowling J, Issel LM, Reeve CL. The dimensionality of adverse childhood experiences: A scoping review of ACE dimensions measurement. Child Abuse Negl. 2021 Nov;121:105270. doi: 10.1016/j.chiabu.2021.105270. Epub 2021 Aug 19. PMID: 34419902.
Copy Download .nbib Format: NLM
Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer.

Breast cancer research and treatment

Nyrop KA, Damone EM, Deal AM, Wheeler SB, Charlot M, Reeve BB, Basch E, Shachar SS, Carey LA, Reeder-Hayes KE, Dees EC, Jolly TA, Kimmick GG, Karuturi MS, Reinbolt RE, Speca JC, Wood WA, Muss HB.
PMID: 34739658
Breast Cancer Res Treat. 2022 Jan;191(2):409-422. doi: 10.1007/s10549-021-06439-6. Epub 2021 Nov 05.

PURPOSE: It is not known whether chemotherapy-related symptom experiences differ between Black and White women with early breast cancer (Stage I-III) receiving current chemotherapy regimens and, in turn, influences dose delay, dose reduction, early treatment discontinuation, or hospitalization.METHODS: Patients...

Cite
Nyrop KA, Damone EM, Deal AM, et al. Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer. Breast Cancer Res Treat. 2021;191(2):409-422doi: 10.1007/s10549-021-06439-6.
Nyrop, K. A., Damone, E. M., Deal, A. M., Wheeler, S. B., Charlot, M., Reeve, B. B., Basch, E., Shachar, S. S., Carey, L. A., Reeder-Hayes, K. E., Dees, E. C., Jolly, T. A., Kimmick, G. G., Karuturi, M. S., Reinbolt, R. E., Speca, J. C., Wood, W. A., & Muss, H. B. (2022). Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer. Breast cancer research and treatment, 191(2), 409-422. https://doi.org/10.1007/s10549-021-06439-6
Nyrop, K A, et al. "Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer." Breast cancer research and treatment vol. 191,2 (2022): 409-422. doi: https://doi.org/10.1007/s10549-021-06439-6
Nyrop KA, Damone EM, Deal AM, Wheeler SB, Charlot M, Reeve BB, Basch E, Shachar SS, Carey LA, Reeder-Hayes KE, Dees EC, Jolly TA, Kimmick GG, Karuturi MS, Reinbolt RE, Speca JC, Wood WA, Muss HB. Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer. Breast Cancer Res Treat. 2022 Jan;191(2):409-422. doi: 10.1007/s10549-021-06439-6. Epub 2021 Nov 05. PMID: 34739658.
Copy Download .nbib Format: NLM
Showing 193 to 194 of 194 entries